'Powerful' weight loss drug to be given to less than 10% of eligible people in first rollout

The health service's watchdog says the "difficult decision" was made to "protect" other NHS services.

Thursday 5 December 2024 09:34, UK

Fewer than 10% of patients in England who are eligible for the weight loss drug Mounjaro will be able to access it on the NHS during the next three years.
Why you can trust Paste BN

Watch Next